Dr. Stanley Riddell, Seattle's Fred Hutch (IMAGE) Fred Hutchinson Cancer Center Caption Dr. Stanley Riddell, an immunotherapy researcher and oncologist at Seattle's Fred Hutchinson Cancer Research Center, will present an update on new adoptive T-cell strategies at the annual meeting of the American Association for the Advancement of Science in Washington, D.C. His presentation will be part of a symposium on the promise and progress of T-cell therapy to fight human diseases. For more than 25 years, Riddell has pioneered experimental therapies that modify and empower the immune system to effectively treat cancers and infectious diseases. Credit Fred Hutch News Service Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.